The Impact of the Covid-19 Pandemic on Orthopedic Trauma Management

The Impact of the Covid-19 Pandemic on Orthopedic Trauma Management; a Cross-sectional Study

The aim of the study is to compare emergency orthopedic trauma admissions between the pre-pandemic period and the pandemic period and to detect changes in orthopedic trauma epidemiology.

Study Overview

• Status: Completed
• Conditions: Trauma; COVID-19 Pandemic
• Intervention / Treatment: Other: epidemyolojical

Detailed Description

The aim of the study is to compare emergency orthopedic trauma admissions between the pre-pandemic period and the pandemic period and to detect changes in orthopedic trauma epidemiology. For this purpose, an epidemiological study was conducted in our country, comparing trauma admissions to a level 1 trauma hospital during a one-year period before the pandemic with those in the year following the onset of the pandemic.Demographic characteristics of the patients, such as age and gender, were recorded. In addition, the injury mechanisms of the patients, diagnosis, injured extremityor anatomical region, broken bone, fracture classification, multitrauma rates, trauma releated complications, hospitalization days, and treatment modalities were examined.

• Study Type: Interventional
• Enrollment (Actual): 57635
• Phase: Not Applicable

Contacts and Locations

Study Locations

• Turkey
  • Istanbul, Turkey
    • University of Health Sciences, Hamidiye Medical School, Bakırköy Dr. Sadi Konuk Education and Research Hospital, Department of Orthopedics and Traumatology

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Child; Adult; Older Adult
• Accepts Healthy Volunteers: No

Description

Inclusion Criteria:

• The patients who were admitted between March 2019 and March 2021
• Patients presenting due to trauma

Exclusion Criteria:

• Patients Admitted Before the Pandemic and Outside the Pandemic Period
• Consultation or Outpatient Clinic Patients
• Non-Traumatic Conditions
• Patients with Incomplete Records

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Screening
• Allocation: Non-Randomized
• Interventional Model: Crossover Assignment
• Masking: Triple

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Other: pre-pandemic group; Patients who presented to the Orthopedics and Traumatology unit for any trauma-related reason during the one-year period prior to the pandemic	Other: epidemyolojical; The aim of the study is to compare emergency orthopedic trauma admissions between the pre-pandemic and pandemic periods, and to identify changes in the epidemiology of orthopedic trauma.; Other Names: Epidemiological
Other: post-pandemic group; Patients who presented to the Orthopedics and Traumatology unit for any trauma-related reason within one year from the start of the pandemic	Other: epidemyolojical; The aim of the study is to compare emergency orthopedic trauma admissions between the pre-pandemic and pandemic periods, and to identify changes in the epidemiology of orthopedic trauma.; Other Names: Epidemiological

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Comparison of Emergency Orthopedic Trauma Admissions Between Pre-Pandemic and Pandemic Period	The main purpose of the study is to compare the changes in the number and quality of emergency orthopedic trauma applications before the COVID-19 pandemic and during the pandemic period.	up to 6 months
Detection of Changes in the Epidemiology of Orthopedic Trauma	The research aims to determine the changes in the epidemiology of orthopedic traumas during the pandemic period compared to before the pandemic. This includes patient demographics, injury mechanisms, diagnoses, injured extremity or anatomical sites, fracture types and classifications, polytrauma rates, trauma-related complications, length of hospital stay, and treatment methods.	up to 6 months

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Changes in Patient Demographic Characteristics	Changes in the age and gender distribution of patients before the pandemic and during the pandemic period.	6 weeks
Comparison of Injury Mechanisms and Diagnoses	Different injury mechanisms and diagnosis distributions during the pandemic period compared to before the pandemic.	8 weeks
Injured Extremities or Anatomical Regions	The extremities or anatomical regions that were most frequently injured before and during the pandemic period.	8 weeks
Fracture Types and Classifications	Changes in fracture types and classifications during the pandemic period.	6 weeks
Trauma-Related Complications	Changes in trauma-related complication rates before the pandemic and during the pandemic period.	6 months
Treatment Methods	Changes in the treatment methods applied before the pandemic and during the pandemic period, especially the increases in surgical treatment rates.	8 weeks
Length of Hospital Stay	Differences in average length of hospital stay before the pandemic and during the pandemic period.	6 weeks

Collaborators and Investigators

• Sponsor: Bakirkoy Dr. Sadi Konuk Research and Training Hospital

Study record dates

Study Major Dates

• Study Start (Actual): March 1, 2019
• Primary Completion (Actual): March 31, 2021
• Study Completion (Actual): November 1, 2021

Study Registration Dates

• First Submitted: January 30, 2024
• First Submitted That Met QC Criteria: January 31, 2024
• First Posted (Actual): February 1, 2024

Study Record Updates

• Last Update Posted (Actual): February 1, 2024
• Last Update Submitted That Met QC Criteria: January 31, 2024
• Last Verified: January 1, 2024

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Coronavirus Infections; Coronaviridae Infections; Nidovirales Infections; RNA Virus Infections; Virus Diseases; Infections; Respiratory Tract Infections; Respiratory Tract Diseases; Pneumonia, Viral; Pneumonia; Lung Diseases; COVID-19; Wounds and Injuries
• Other Study ID Numbers: 2021-168

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: UNDECIDED

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No